Administration of B7-H3 targeted chimeric antigen receptor-T cells induce regression of glioblastoma.

ABSTRACT:

SUBMITTER: Tang X 

PROVIDER: S-EPMC7994554 | biostudies-literature | 2021 Mar

REPOSITORIES: biostudies-literature